Wellgistics Health (WGRX)
Connects drug manufacturers, pharmacies, and patients through wholesale distribution and prescription hub services.
Something off on this page? Send us feedback.
Wellgistics Health is a Nasdaq-listed healthcare company centered on pharmaceutical wholesale distribution, pharmacy services, and a technology-enabled prescription hub. Its model links manufacturers, independent pharmacies, providers, and patients, while depending on regulatory compliance, capital access, and adoption by pharmacy and manufacturer partners.
Wellgistics Health, formerly Danam Health, is a Tampa-based holding company for pharmacy, wholesale distribution, and health technology operations. Its Wellgistics LLC unit is an FDA-licensed and NABP-accredited pharmaceutical wholesaler that distributes branded, generic, over-the-counter, specialty-lite, and niche products to independent pharmacies and manufacturers across the United States.
The company also offers third-party logistics such as warehousing, inventory management, pick-and-pack, and shipping, and it describes DelivMeds as a hub platform for prescription routing, benefits work, care coordination, adherence support, and clinical services. Wellgistics is trying to position its platform as an alternative channel between manufacturers, pharmacies, providers, payors, and patients. Its execution depends on compliance in a regulated pharmacy supply chain, partner adoption, access to working capital, and the company’s ability to address its reported going-concern uncertainty.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $2.5M · Total debt $32.6M · Total assets $32.8M · Shareholders' equity −$19.5M
- Revenue
- $1.8M
- Operating income
- −$7.3M
- Net income
- −$18.4M
No dividends on record.
| Institutions13 holders · as of Mar 31, 2026 | ≥ 1.39% | 42.7K shares | |
| Insiders9 holders · as of Apr 24, 2025 | 16.61% | 508.7K shares | |
| Otherremainder | ≤ 82.00% | 2.51M shares |
3.06M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (3.06M in the company's Sep 3, 2026 report, 2.46M elsewhere); stakes use the report.
Institutional filings for MEDS (100% of the company) are not on file here, so the institutional figure is a floor.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Brian NortonInsiderofficer: Chief Executive Officer | 7.40% | 226,487 | Form 4filed Mar 25, 2025 ↗ |
Prashant PatelInsiderdirector, officer: Chief Strategy Officer | 4.13% | 126,365 | Form 4filed Mar 25, 2025 ↗ |
Surendra K. AjjarapuInsiderdirector | 4.11% | 125,709 | Form 4filed Mar 25, 2025 ↗ |
Geode Capital Management, LLCInstitution | 0.46% | 710,766 | 13Fas of Mar 31, 2026 |
Vanguard Capital Management LLCInstitution | 0.39% | 604,226 | 13Fas of Mar 31, 2026 |
| See all 22 → | |||
13F — a manager's quarterly holdings · Form 4 — an insider's transaction report
Insider tradesForm 4
Nothing filed in the last 12 months.
Not reported.